DOCSLIB.ORG

Medical Laboratory Technician--Hematology, Serology, Blood Banking, and Immunohematology (AFSC 90470)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medical Laboratory Technician--Hematology, Serology, Blood Banking, and Immunohematology (AFSC 90470) DOCUMENT RESUME ED 268 334 CE 044 216 AUTHOR Thompson, Joselyn H. TITLE Medical Laboratory Technician--Hematology, Serology, Blood Banking, and Immunohematology (AFSC 90470). INSTITUTION Air Univ., Gunter AFS, Ala. Extension Course Inst. PUB DATE 25 May 84 NOTE 353p.; Supersedes ED 224 893. PUB TYPE Guides Classroom Use Materials (For Learner) (051) EDRS PRICE MF01/PC15 Plus Postage. DESCRIPTORS *Allied Health Occupations Education; Behavioral Objectives; Biomedical Equipment; Correspondence Study; Distance Education; *Laboratory Procedures; *Laboratory Technology; Learning Activities; *Medical Evaluation; Medical Services; *Medical Technologists; Military Personnel; *Military Training; Postsecondary Education IDENTIFIERS Air Force; Blood Transfusion; *Hematology; Immunology; Serology ABSTRACT This three-volume student text is designed foruse by Air Force personnel enrolled in a self-study extensioncourse for medical laboratory technicians. Covered in the individual volumesare hematology (the physiology of blood, complete blood counts and related studies, erythrocyte studies, leukocyte and thrombocyte maturation, and blood coagulation studies); laboratory procedures in blood banking and immunohematology (immunohematology, bloodgroup systems, transfusion and transfusion practices, and the blood donor center); and serology (principles of immunology and serology; agglutination tests; latex-fixation, precipitin, and ASO tests; and serological tests for syphilis). Each volume in the set containsa series of lessons, exercises at the end of each lesson, a bibliography, and answers to the exercises. Supplementary volume review exercises and a change supplementare also provided. (MN) *********************************************************************** * Reproductions supplied by EDRS are the best that can be made * * from the original document. * *********************************************************************** MEDICAL LABORATORY TECHNICIAN--HEMATOLOGY, SEROLOGY, BLOOD BANKING AND IMMUNOHEMATOLOGY (AFSC 90470) U.S. DEPARTMENT OF EDUCATION N TIONAL INSTITUTE OF EDUCATION EXTENSION COURSE INSTITUTE E CATIONAL RESOURCES INFORMATION CENTER (ERICI This document has been reproducedas AIR UNIVERSITY received from the person ororganization originating it Minor changes have been madeto improve reproduction quality Points of view or opinions statedin this docu ment do not necessarily represent official NIE position or policy 2 ECI COURSE MATERIALS SHIPPING LIST [BOURSE COURSE TI TLE EFFECTIVE OATS NO MEDICAL LABORATORY TECHNICIAN-HEMATOLOGY OF SHIPPING LIST 90413 SERPLOQL BLOOD BANKING AND IMMUNOHEMATOLOGY 25 May 84 (AFSC 92470) INSTRUCTIONSThe following materials ore needed to complete 1114 Male.Check thislist immediatelupon receiving you. course package,and if any materials are missing or incorrect (numbers don'tmatch) notify ECI immediately. Use tile ECi Four, 17 for thispurpose, and be sure to include your identification number, address,course and volume number, and VRE form designation(if a VRE isinvolved). Send all correspondence separately fromyour answer shoot. VRE ANSWER SHEET ITEM TYPE INVENTORY CONTROL DESIGNATION OR TITLE NUMBER I OEN TI FI CATI ON 1 ENV ECI RETURN ENVELOPE:, (4 EACH) 2 YOUR KEY TO A SUCCESSFUL COURSE M-140 3 VOL VOL 1, Hematology 90413 01 7706 4 VRE i----.4 "irt.nVOLUME REVIEW EXERCISE (VOL 1) 90413 01 22 90413 01 22 5 VOL Blood Banking and Immunohematology 90413 02 7708 6 VRE VOLUME REVIEW EXERCISE (VOL 2) 90413 02 23 90413 02 23 7 VOL VOL 3, Serology 90413 03 7709 8 VRE VOLUME REVIEW EXERCISE (VOL 3) 90413 03 23 90413 03 23 9 ECI SURVEY 99-01 99-01 NOTE: DIRECT ANY QUESTIONS OR COMMENTS RELATING TO ACCURACY OR CURRENCY OF TEXTUAL MATERIALS TO AUTOVON 736-2809. r YOU ARE NOT REQUIRED TO POST ANY CHANGES LISTED ON THIS SHIPPING LIST WHICH CORRECT TYPOGRAPHICAL ERRORS, UNLESS SUCH ERRORS CHANGE OR OTHER- WISE AFFECT THE MEANING OF THE MATERIAL, SPECIAL NOTE: DISREGARD THE AFSC 90470 PRTNTVTIAIN_TRFLT97113_0V V TEXTS. THIS CDC IS FOR AIRMEN ON UPGRADE TRAINING TO AFSC 92470 ONLY. CHANGE THE CURRENCY DATE ON ALL VOLUMES TO "MARCH 1984." ECIF"m 25 Oct 73 (Page 1 of 2 ) (SEE REVERSE SIDE FOR ADDITIONAL INSTRUCTIONS) 3 UST OF CHANGES COURSE CAREER FIELDS, POLICIES, PROCEDURES AND EQUIPMENT CHANGE. ALSO ERRORS NO. OCCASIONALLY GET INTO PRINT. THE FOLLOWING ITEMS UPDATE AND CORRECT 90413 YOUR COURSE MATERIALS. PLEASE M4KE THE INDICATED CHANGES. FECTIVEDATE OF SHIPPING UST 84 SPECIAL NOTE: THROUGHCUT THE TEXTS AND VOLUME REVIEW EXERCISES FOR THIS COURSE, CHANGE FIRST 3 DIGITS OF ALL AFSCs FROM "904" to "924." 1. CHTNGES FOR THE TEXT: VOLUME 1 a. Page 2, col 1, line 9 from bottom: Change "45,000 to "375,000" to "140,000 to 444,000." b. Page 58, col 2, line 11: Change "12- x 75-mm" to "10- x 75-mm." c. Page 107, answer 040-9: Change "12- x 75-mm" to "10- x 75-mm." 2. CHANGES FOR THE VOLUME REVIEW EXERCISE. VOLUME 1 a. Page 8, question 65, last line: Change choice "b" to "d." b. Page 9, question 73: Change "(045)" to "(046)." c. Page 12, question 105, choice a: Change "hyperplasia" to "hypoplasia." d. Page 13, question 112: In thestem of the question, change "Breaker- Cronkite" to "Brecker-Cronkite." e. Page 14, question 121: At thebeginning of the stem of the question, insert "In the prothrombin consumptiontest." f. The following questions are nolonger scored and need not be answered: 1 and 74. 3. CHANGES FOR THE VOLUME REVIEW EXERCISE: VOLUME 2 a. Page 8, question 56: In the stem of the question, change "incomplete" to "incompatible." o b. Page 11, question 87: In the stem of the question, change "1 C. to o o 1 C." to "1 C. to 6° C." c. The following questions are no longer scored and need not be answered: 64 and 79. 4. CHANGES FOR THE VOLUME REVIEW EXERCISE: VOLUME 3 a. Page 2, question 4: In the stem of the question, insert "certain" between "has" and "gram." Question 5: In the stem of the question, insert "lack the" between "mechanisms" and "specificity." b. The following questions are no longer scored and need not be answered: (Page 2 of ) ECI Form 25 90413 01 7706 CDC 90413 MEDICAL LABORATORY TECHNICIAN HEMATOLOGY, SEROLOGY, BLOOD BANKING ANDIMMUNOHEMATOLOGY (AFSC 90470) Volume 1 Hematology 1,VINN1*%M%NNWWW11A1AAV1MANNVNYWIMAMAV1{/fef bVV%%% IVM,!,1ANIAVo,~4N41i1sinNVVY111AMANVo1VWLIA4WA' Extension Course Institute Air University 5 Prepared by MSgt Joselyn H. Thompson School of Health Care Sciences (ATC) Sheppard AFB, Texas 76311 Reviewed by Elmore C. Hall, Education Specialist Extension Course Institute (AU) Gunter AFS, Alabama 36118 PREPARED BY SCHOOL OF HEALTH CARE SCIENCES, USAF (ATC) SHEPPARD AIR FORCE BASE, TEXAS EXTENSION COURSE INSTITUTE, GUNTER AIR FORCE STATION, ALABAMA THIS PUBLICATION HAS BEEN REVIEWED AND APPROVED BY COMPETENT PERSONNEL OF THE PREPARING COMMAND IN ACCORDANCE WITH CURRENT DIRECTIVES ON DOCTRINE, POLICY, ESSENTIALITY, PROPRIETY, AND QUALITY. 6 Preface THIS COURSE, the final one in the Medical Laboratory Technician series, is made up of three vol- umes. These three volumes include hematology, blood banking, and serology. A glossary of technical terms used in Volumes 1, 2, and 3 of this CDC is printed at the back of Volume 3. Chapter 1 of this volume provides a brief review on blood physiology. Chapter 2 discusses the com- plete blood count and related studies. Chapters 3 and 4 review more recent concepts in erythrocytes studies and leukocyte and thrombocyte maturation, with emphasis on application to the various classes of laboratories and their capabilities. Chapter 5, on blood coagulation studies, provides a new dimen- sion in understanding the function and significance of coagulation factors, tests, and interpretation required to identify many coagulation problems. Foldouts 1 and 2 are printed and bound in the back of this volume. Whenever you are referred to one of these foldouts in the text, please turn to the back of the volume and locate it. Please note that in this volume we are using the singular pronoun he, his, or him in the generic sense, not the masculine sense. The word to which it refers is person. If you have questions on the accuracy or currency of the subject matter of this text, or recommenda- tions for its improvement, send them to the School of Health Care Sciences/ MSTW, Sheppard AFB TX 76311. NOTE: Do not use the suggestion program to submit corrections for typographical or other errors. If you have questions on course enrollment or administration, or on any of ECI's instructional aids (Your Key to Career Development, Behavioral Objective Exercises, Volume Review Exercise, and Course Examination), consult your education officer, training officer, or NCO, as appropriate. If he can't answer your questions, send them to ECI, Gunter AFS AL 36118, preferably on ECI Form 17, Student Request for Assistance. This volume is valued at 36 hours (12 points). Material in this volume is technically accurate, adequate, and current as of April 1976. II, Contents Page Preface "I Chapter I The Physiology of the Blood I 2 The Complete Blood Count and Related Studies 12 3 Erythrocyte Studies 50 4 Leukocyte and Thrombocyte Maturation 63 5 Blood Coagulation Studies 74 Bibliography 101 Answers for Exercises 103 8 iv 1 CHAPTER 1 NOTE: In this volume, the subject matter is developed bya series of Learning Objectives. Each of these carries a 3-digit number and is in boldface type. Each setsa learning goal for 7ou. The text that follows the objective gives you the information you need to reach that goal. The exercisesfollowing the information give you a check on your achievement. Whenyou complete them. see if 'our answers match those in the back of this volume. If your response to an exercise is incorrect, reviewthe objective and its text. The Physiology of Blood THE WORD "HEMATOLOGY" is derived from the the leukocytes (WBCs), as well as the platelets or Greek words, alma, meaning blood, and togasmean- thrombocytes. Where do these cellular elements come ing study. In this chapter, we will rev iew the composi- from and what are their functions? First, let's look tion and functions of blood. Blood is a tissue in which at the RBCs.
Load more

Recommended publications
  • Age-Related Features and Pathology of Blood in Children
    MINISTRY OF PUBLIC HEALTH OF UKRAINE HIGHER STATE EDUCATIONAL ESTABLISHMENT OF UKRAINE «UKRAINIAN MEDICAL STOMATOLOGICAL ACADEMY» V.I. POKHYLKO, S.M. TSVIRENKO, YU.V. LYSANETS AGE-RELATED FEATURES AND PATHOLOGY OF BLOOD IN CHILDREN MANUAL FOR STUDENTS OF HIGHER MEDICAL EDUCATIONAL INSTITUTIONS OF THE III-IV ACCREDITATION LEVELS Poltava 2017 МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я УКРАЇНИ ВИЩИЙ ДЕРЖАВНИЙ НАВЧАЛЬНИЙ ЗАКЛАД УКРАЇНИ «УКРАЇНСЬКА МЕДИЧНА СТОМАТОЛОГІЧНА АКАДЕМІЯ» ПОХИЛЬКО В.І., ЦВІРЕНКО С.М., ЛИСАНЕЦЬ Ю.В. ВІКОВІ ОСОБЛИВОСТІ ТА ПАТОЛОГІЯ КРОВІ У ДІТЕЙ НАВЧАЛЬНИЙ ПОСІБНИК ДЛЯ СТУДЕНТІВ ВИЩИХ МЕДИЧНИХ НАВЧАЛЬНИХ ЗАКЛАДІВ III-IV РІВНІВ АКРЕДИТАЦІЇ Полтава 2017 2 UDC: 616+616.15]-053.2(075.8) ВВС: 57.33я73 The manual highlights the issues of embryogenesis, age-related features, semiotics of lesion, examination methods and diseases of hemic system in children. The manual is intended for students of higher educational institutions of III-IV accreditation levels, and can be used by medical interns and primary care doctors. Authors: Doctor of Medical Sciences, Professor of the Department of Pediatrics No.1 with Propedeutics and Neonatology V.I. Pokhylko Candidate of Medical Sciences, Acting Head of the Department of Pediatrics No.1 with Propedeutics and Neonatology S.M. Tsvirenko Candidate of Philological Sciences, Senior Lecturer of the Department of Foreign Languages with Latin and Medical Terminology Yu.V. Lysanets Reviewers: O.S. Yablon’ ― Doctor of Medical Sciences, Professor, Head of the Department of Pediatrics No.1, Vinnytsya National M.I. Pirogov Memorial Medical University of Ministry of Public Health of Ukraine. M.O. Honchar ― Doctor of Medical Sciences, Professor, Head of the Department of Pediatrics and Neonatology No.1, Kharkiv National Medical University.
    [Show full text]
  • • Cytosis: O Neutrophilia: Defined As an Increase in the Neutrophilic Count in the Peripheral Blood Above Reference Range for Age
    HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS-UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD NONNEOPLASTIC DISEASES OF THE WHITE BLOOD CELLS • There are five major types of WBCs in the blood: neutrophils, lymphocytes, eosinophils, basophils and monocytes. • The normal function of the white blood cells depends on a tight regulation of their count and their function. Therefore, disease develops if there is a derangement of the cells count or function, it takes one of the following forms: o Cytosis: increase in the number of circulating cells above reference range. (Note: leukocytosis means an increase in the WBC count, neutrophilia means increase in the neutrophilic count, lymphocytosis means increase in the lymphocytic count, monocytosis means increase in the monocytic count, basophilia means increase in the basophilic count and eosinophilia means in crease in the eosinophilic count). o Cytopenia: decrease in the number of circulating cells below reference range. (Note: neutropenia means decreased neutrophils, lymphocytopenia, or simply lymphopenia, means decrease in lymphocytes, monocytopenia means decrease in monocytes, eosinopenia means decrease in eosinophils, and basopenia means decrease in basophils). o Abnormal or absent function • Cytosis: o Neutrophilia: defined as an increase in the neutrophilic count in the peripheral blood above reference range for age. o Causes: bacterial infection is the most common and most important etiology. Tissue necrosis in cases of burns or trauma and medications such as epinephrine and corticosteroids are also additional causes for neutrophilia. § Some physiologic conditions can lead to neutrophilia such as stress, smoking and pregnancy. o Pathophysiology: neutrophils are present in the blood in two populations: circulating and marginal (meaning neutrophils stuck to the vessel wall).
    [Show full text]
  • Study of Osmotic Fragility Status of Red Blood Cell in Type II Diabetes Mellitus Patients
    European Journal of Environment and Public Health, 2017, 1(2), 06 ISSN: 2468-1997 Study of Osmotic Fragility Status of Red Blood Cell in Type II Diabetes Mellitus Patients Nihad Rownak1, Shahin Akhter2, Monira Khatun3, Sohel Baksh4, Shafquat Rafiq5*, Mushfiqur Rahman6 1 Department of Physiology, University of Science & Technology Chittagong, BANGLADESH 2 Department of Physiology, Chittagong Medical College, Chittagong, BANGLADESH 3 Department of Physiology, Chattagram Maa O Shishu Hospital Medical College, Chittagong, BANGLADESH 4 Department of Physiology, Cox’s Bazar Medical College, BANGLADESH 5 Croydon University Hospital NHS Trust, UNITED KINGDOM 6 Department of Pediatric Surgery, Chittagong Medical College, Chittagong, BANGLADESH *Corresponding Author: [email protected] Citation: Rownak, N., Akhter, S., Khatun, M., Baksh, S., Rafiq, S., and Rahman, M. (2017). Study of Osmotic Fragility Status of Red Blood Cell in Type II Diabetes Mellitus Patients. European Journal of Environment and Public Health, 1(2), 06. https://doi.org/10.20897/ejeph/77094 Published: December 28, 2017 ABSTRACT Diabetes Mellitus (DM) is one of the most prevalent non-communicable diseases in the world. Cell membrane injury is an important mechanism for pathophysoilogical changes in DM. Osmotic fragility (OF) status of Red blood cell (RBC) in hyperglycemic patients is expected to be increased. This study was conducted in Chittagong medical college hospital and Chittagong Diabetic Hospital from January 2015 to December 2015. 100 newly diagnosed (duration ≤ 3 years) type II diabetes mellitus patients (Fasting blood glucose is ≥7 mmol/L) were selected as cases. Age, sex and BMI matched 100 healthy subjects were included as control. OF of RBC was measured by traditional method with a series of hypotonic solution of NaCl of different strength in twelve test tubes numbered serially.
    [Show full text]
  • 47 Effect of Gavage Treatment with Pulverised
    47 Nigerian Journal of Physiological Sciences 24 (1): 47-52 © Physiological Society of Nigeria, 2009 Available online/abstracted at http://www.biolineinternational.org.br/nps; www.ajol.info/journals.njps; www.cas.org EFFECT OF GAVAGE TREATMENT WITH PULVERISED GARCINIA KOLA SEEDS ON ERYTHROCYTE MEMBRANE INTEGRITY AND SELECTED HAEMATOLOGICAL INDICES IN MALE ALBINO WISTAR RATS A. A. AHUMIBE AND V. B. BRAIDE* Department of Pharmacology, Faculty of Basic Medical Science, College of Medical sciences, University of Calabar, PMB 1115, Calabar, Nigeria. E-mail: [email protected]. Tel.:+2348034048101 Summary: This study examines the effect of the whole seed of Garcinia kola (GKS ) on various blood parameters, in adult male albino rats. Five groups, of 6 animals per group, were treated by gavage with suspensions of graded concentrations of GKS daily for 5 weeks. The animals were then sacrificed and blood was obtained for estimation of the data herein presented. Packed red cell volume (PCV), hemoglobin concentration (Hb), and red blood cell count (RBC) showed significantly (P < 0.05, Student’s t-test) increased response to treatment with GKS; while the platelet and white blood cell (WBC) counts showed no corresponding increase with increasing GKS dosage. The mean red blood cell volume (MCV) and mean cell hemoglobin (MCH) levels decreased with increasing GKS dosage. Prothrombin time (PT) and activated partial thromboplastin time (APPT) were both prolonged with increased GKS dosage; while the serum lipids (cholesterol and triglycerides) decreased significantly (P< 0.05, Student’s t-test) with increased GKS dosage. Key Words: Garcinia kola; erythrocyte osmotic fragility; haematological parameters; serum cholesterol triglycerides Introduction One of many plant sources of therapeutic 2000); hypoglycaemic anti-diabetic activity (Iwu et ingredient among the people in West and Central al , 1990); bronchodilatation in man (Orie and Ekon Africa and some parts of Asia, is the seed plant 1993); antispasmodic effect on smooth muscle Garcinia kola Heckel (Guttiferae).
    [Show full text]
  • B- and T-Cell Neoplasm Features and Fine Points
    B- and T-cell neoplasm features and fine points Karen Lusky June 2021—A case of monoclonal B-cell lymphocytosis and a tour of B- and T-cell morphologies were at the heart of a CAP20 virtual presentation on neoplastic lymphocytosis. Kyle Bradley, MD, associate professor of hematopathology and director of surgical pathology at Emory University, spoke last fall on reactive (CAP TODAY, May 2021) and neoplastic lymphocytosis, with Olga Pozdnyakova, MD, PhD, who addressed neutrophilia and monocytosis (CAP TODAY, February and March 2021). Together they took attendees through a morphology-based approach to hematopoietic neoplasms presenting with an abnormal WBC differential. “Some malignant lymphocytes can closely resemble normal cells,” Dr. Bradley said in a recent interview. “The classic example would be chronic lymphocytic leukemia because individual lymphocytes in that neoplasm can look very similar to normal lymphocytes.” Dr. Bradley shared the case of a 59-year-old man with a clonal B-cell population identified by flow cytometry. It was positive for CD19, CD20, CD5, CD23, CD200, and Kappa, and negative for CD10, FMC7, and Lambda. “This is a typical phenotype for chronic lymphocytic leukemia/small lymphocytic lymphoma,” he said. However, “the blood smear is not what you typically think of for CLL.” (Fig. 1). The differential diagnosis is CLL versus monoclonal B-cell lymphocytosis, he said. In the current and previous WHO classification, CLL requires greater than 5.0 × 109/L clonal B cells. Lower counts are acceptable if there are signs or symptoms of lymphoma. Monoclonal B-cell lymphocytosis is defined as ≤ 5.0 × 109/L clonal B cells in otherwise healthy subjects.
    [Show full text]
  • Anormal Rbc in Peripheral Blood. [Repaired].Pdf
    1. Acanthocyte 2. Burr-cell 3. Microcyte 1. Basophilic Normoblast 2. Polychromatic Normoblast 3. Pycnotic Normoblast 4. Plasmocyte 5. Eosinophil 6. Promyelocyte 1. Macrocyte 2. Elliptocyte 1. Microcyte 2. Normocyte 1. Polychromatic Erythrocyte 2. Acanthocyte 3. Elliptocyte 1. Polychromatic Normoblast 2. Pycnotic Normoblast 3. Neutrophil Myelocyte 4. Neutrophil Metamyelocyte 1. Schistocyte 2. Microcyte BASOPHILIC ( EARLY ) NORMOBLASTS Basophilic Erythroblast Basophilic Stippling, Blood smear, May-Giemsa stain, (×1000) CABOT'S RINGS Drepanocyte Elliptocyte Erythroblast ERYTHROBLAST in the blood Howell-jolly body Hypo chromic LACRYMOCYTES Leptocyte Malaria, Blood smear, May-Giemsa stain, ×1000 MICROCYTES Orthochromatic erythroblast Pappen heimer Bodies & 1. Schistocyte 2. Elliptocyte 3. Acanthocyte POIKILOCYTOSIS Polychromatic Erythroblast Pro Erytroblast Proerythroblasts Reticulocyte Rouleaux SICKLE CELLS Sickle cell Spherocyte Spherocyte Spherocyte SPHEROCYTES STOMATOCYTES Target Cells Tear Drop Cell, Blood smear, May-Giemsa stain, x1000 Anulocyte 1. Burr-cell 2. Elliptocyte 1. Macrocyte 2. Microcyte 3. Elliptocyte 4. Schistocyte 1. Ovalocyte 2. Lacrymocyte 3. Target cell 1. Polychromatic Erythrocyte 2. Basophilic Stippling 1. Proerythroblast 2. Basophilic Erythroblast 3. Intermediate Erythroblast 4. Late Erythroblast 5. Monocyte 6. Lymphocyte 1. Target-cell 2. Elliptocyte 3. Acanthocyte 4. Stomatocyte 5. Schistocyte 6. Polychromatophilic erythrocyte. 1.Pro erythroblast 2.Basophilic normoblast 3.Polychromatic normoblast 4.Pycnotic normoblast
    [Show full text]
  • Leukemoid Reaction in a Patient with Acute Lymphoblastic Leukemia Following the Second Chemotherapy
    262JCEI / Yokuş et al. Leukemoid reaction in ALL 2013; 4 (2): 262-263 Journal of Clinical and Experimental Investigations doi: 10.5799/ahinjs.01.2013.02.0280 LETTER TO EDITOR Leukemoid reaction in a patient with acute lymphoblastic leukemia following the second chemotherapy Akut lenfoblastik lösemili hastada ikinci kemoterapi sonrası gelişen lökomoid reaksiyon Osman Yokuş1, Murat Albayrak2, Aynur Albayrak3, Habip Gedik4 To the Editor, to 50.000 cells/µL. The examined peripheral blood smear appeared as similar to the chronic phase of The occurrence of persistent neutrophilic leukocy- CML (fig.2). A cytogenetic examination of Philadel- tosis above 50,000 cells/µL for reasons other than phia chromosome [t(9:22] was found to be nega- leukemia is defined as leukemoid reaction. Chronic tive, therefore, CML was excluded in the patient. myelogenous leukemia (CML) and chronic neutro- Hydroxurea was initiated once a day. Leukocytosis philic leukemia (CNL) should be excluded, and un- recovered to normal range after one week (fig.3) derlying diseases or causes should be examined, and bone marrow examination revealed remission. in differential diagnosis. The most commonly ob- Cytogenetic analysis was normal and this leukocy- served causes of leukemoid reactions are severe tosis was determined as reactive leukemoid reac- infections, intoxications, malignancies, severe hem- tion. We aimed to report this case owing to the fact orrhage, or acute hemolysis [1]. J Clin Exp Invest that leukocytosis associated with G-CSF, which is 2013; 4 (2): 262-263 used to increase the leukocyte count during neutro- Rarely, leukemoid reaction can be seen in pa- penia, has been reported previously but it occurred tients with acute leukemia subsequent to chemo- after second chemotherapy without G-CSF [4].
    [Show full text]
  • Wikipedia: the Term Leukemoid Reaction Describes an Elevated White Blood
    Correspondence: I. Potasman, MD Leukemoid Reaction: Spectrum and Prognosis of 173 Adult Patients Infectious Diseases, ABSTRACT No. Bnai Zion Med. Ctr. 47 Golomb St., Haifa 31048. 39147 Israel Potasman, MD and Moti Grupper, MD Tel. 972-48359055 Fax. 972-48359755 Bnai Zion Med. Ctr., Haifa, Israel Email: [email protected] LR- CLINICAL and LABORATORY FEATURES CHRONIC DISEASES & CONDITIONS CAUSING LR METHODS WikipediA: The term leukemoid reaction describes an elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection (as Table 1: Leukemoid Reaction: Demographics, Major Clinical, and Laboratory features, and Table 2: Chronic & possible Instigating diseases Causing Leukemoid Reaction (n=173) The BZMC is a 411 bed university hospital located in Haifa, Israel. Mortality (n=173) Disease/Drug Occurrences (%) opposed to a primary blood malignancy, such as leukemia). Contains all basic departments except for neurosurgery, cardiovascular surgery and solid-tumor oncology. The respi- Parameter N (%) Alive Dead n Age (years, mean ±S.D.) 69.4 ±19.6 63.3±21.2 79.4±11.2 Background ratory intensive care unit inhabits six patients; additional respirators are in use in the 3 departments of medicine. History of Cardiovascular 86 (49.7%) Minimal-Maximal 21-97 21-97 28-97 ABSTRACT During an average year there are 29,508 hospitalizations of adults (>18 years) with ~150,000 hospitalization-days, Median 75 69 81 disease Diabetes Mellitus 46 (26.6%) and an average occupancy of 92%. Patients were eligible throughout hospital stay, and wherever they were admit- Chronic Lung disease 29 (16.8%) ted.
    [Show full text]
  • ISTH Couverture 6.6.2012 10:21 Page 1 ISTH Couverture 6.6.2012 10:21 Page 2 ISTH Couverture 6.6.2012 10:21 Page 3 ISTH Couverture 6.6.2012 10:21 Page 4
    ISTH Couverture 6.6.2012 10:21 Page 1 ISTH Couverture 6.6.2012 10:21 Page 2 ISTH Couverture 6.6.2012 10:21 Page 3 ISTH Couverture 6.6.2012 10:21 Page 4 ISTH 2012 11.6.2012 14:46 Page 1 Table of Contents 3 Welcome Message from the Meeting President 3 Welcome Message from ISTH Council Chairman 4 Welcome Message from SSC Chairman 5 Committees 7 ISTH Future Meetings Calendar 8 Meeting Sponsors 9 Awards and Grants 2012 12 General Information 20 Programme at a Glance 21 Day by Day Scientific Schedule & Programme 22 Detailed Programme Tuesday, 26 June 2012 25 Detailed Programme Wednesday, 27 June 2012 33 Detailed Programme Thursday, 28 June 2012 44 Detailed Programme Friday, 29 June 2012 56 Detailed Programme Saturday, 30 June 2012 68 Hot Topics Schedule 71 ePoster Sessions 97 Sponsor & Exhibitor Profiles 110 Exhibition Floor Plan 111 Congress Centre Floor Plan www.isth.org ISTH 2012 11.6.2012 14:46 Page 2 ISTH 2012 11.6.2012 14:46 Page 3 WelcomeCommittees Messages Message from the ISTH SSC 2012 Message from the ISTH Meeting President Chairman of Council Messages Dear Colleagues and Friends, Dear Colleagues and Friends, We warmly welcome you to the elcome It is my distinct privilege to welcome W Scientific and Standardization Com- you to Liverpool for our 2012 SSC mittee (SSC) meeting of the Inter- meeting. national Society on Thrombosis and Dr. Cheng-Hock Toh and his col- Haemostasis (ISTH) at Liverpool’s leagues have set up a great Pro- UNESCO World Heritage Centre waterfront! gramme aiming at making our off-congress year As setting standards is fundamental to all quality meeting especially attractive for our participants.
    [Show full text]
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Anemic Syndrome and White Blood Cells Disorders
    27. 11. 2020 Anemic syndrome and white blood cells disorders Kristína Repová, M.D., PhD. [email protected] Institute of Pathophysiology, Faculty of Medicine, Bratislava Prepared exclusively for the purposes of distance education at the Faculty of Medicine, Comenius University in Bratislava in 2020/21 Hematopoeisis • Hematopoietic organs: • Bone marrow: • forming of erythrocytes, granulocytes, monocytes, thrombocytes, partially lymphocytes • Thymus: • forming of T-lymphocytes • Lymphatic nodes, tonsils, spleen: • forming of B-lymphocytes lymphoid multipotent stem cell pluripotent progenitor cell precursor cell stem cell myleoid multipotent stem cell 1 27. 11. 2020 Hematopoeisis 3 Pluripotent hematopoietic stem cell (self-renewal) Myeloid multipotent Lymphoid multipotent stem cell stem cell Megacaryocyte and Granulocyte and T-cell and NK B-cell erythroid progenitor Macrophage progenitor cell progenitor progenitor Megacaryocyte Erythrocyte Granulocyte Monocyte progenitor progenitor progenitor progenitor (CFU-Meg) (CFU-E) (CFU-G) (CFU-M) Myeloblast NK-cell Proerythroblast Monoblast Lymphoblast Lymphoblast Promyelocyte Megacaryoblast Erythroblast Myelocyte Promonocyte Prolymphocyte Prolymphocyte Megacaryocyte Reticulocyte Metamyelocyte Monocyte T-cell B-cell Thrombocyte Erythrocyte Band cell Basophil Eosinophil Macrophage Dendritic cell Neutrophil 2 27. 11. 2020 I. Disorders of red blood cells II. Disorders of white blood cells III. Myeloproliferative and lymphoproliferative disorders I. Disorders of red blood cells 1. Anemia 2.
    [Show full text]
  • The Diagnostic Importance of Coagulation Parameters in Cattle Having Natural Theileriosis
    Polish Journal of Veterinary Sciences Vol. 20, No. 2 (2017), 369–376 DOI 10.1515/pjvs-2017-0045 Original article The diagnostic importance of coagulation parameters in cattle having natural theileriosis V. Gunes, A.C. Onmaz, I. Keles, K. Varol, G. Ekinci Erciyes University, Faculty of Veterinary Medicine, Department of Internal Medicine, Kayseri, 38100 Turkey Abstract The purpose of this study was to determine the diagnostic importance of coagulation parameters in cattle with natural theileriosis. Nine Holstein cross-breed cattle with theileriosis as infected group and 6 healthy Holstein cattle as control group were used in the present study. Mean fibrinogen level, thrombin time (TT), activated partial thromboplastin time (aPTT) and prothrombin time (PT) were not statistically different when control and infected groups compared, except for the D-dimer concen- tration. Quantitative D-dimer concentrations were determined by immune-turbidimetric assay. D-dimer values increased significantly (p<0.05) in infected group (631.55 ± 74.41 μg/L) compared to control group (370.00 ± 59.94 μg/L). D-dimer sensitivity and specificity were also determined at cut-off concentrations (372 μg/L). Sensitivity and specificity of D-dimer values were determined to be 88.89% and 83.33%, respectively. D-dimer is thought to be important indicator in the evaluation of the prognosis in theileriosis cases. Analysis of D-dimer values before and after treatment in controlled case studies were suggested in future studies to enlighten the issue. Key words: cattle, coagulopathy, D-dimer, haemolysis, theileriosis Introduction common. Haemolytic anaemia, icterus and death has been reported in the advanced stages of the disease Theileriosis is a protozoan disease transported to (Keles et al.
    [Show full text]